Literature DB >> 22717452

Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis.

Bernd Schnabl1, David A Brenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22717452      PMCID： PMC4077319          DOI： 10.1136/gutjnl-2012-302644

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  13 in total

1.  TWEAK induces liver progenitor cell proliferation.

Authors:  Aniela Jakubowski; Christine Ambrose; Michael Parr; John M Lincecum; Monica Z Wang; Timothy S Zheng; Beth Browning; Jennifer S Michaelson; Manfred Baetscher; Manfred Baestcher; Bruce Wang; D Montgomery Bissell; Linda C Burkly
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

2.  Cause of death in alcoholic hepatitis.

Authors:  Phillip O Coffin; Bradley A Sharpe
Journal:  J Hosp Med       Date:  2007-01       Impact factor: 2.960

3.  Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis.

Authors:  M E Felver; E Mezey; M McGuire; M C Mitchell; H F Herlong; G A Veech; R L Veech
Journal:  Alcohol Clin Exp Res       Date:  1990-04       Impact factor: 3.455

4.  Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.

Authors:  Janina E E Tirnitz-Parker; Cornelia S Viebahn; Aniela Jakubowski; Borut R S Klopcic; John K Olynyk; George C T Yeoh; Belinda Knight
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

5.  Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.

Authors:  M Yin; M D Wheeler; H Kono; B U Bradford; R M Gallucci; M I Luster; R G Thurman
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

6.  Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis.

Authors:  Charu Dogra; Susan L Hall; Nia Wedhas; Thomas A Linkhart; Ashok Kumar
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

7.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

8.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Authors:  Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2008-09-13       Impact factor: 22.682

9.  A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.

Authors:  Sylvie Naveau; Sylvie Chollet-Martin; Sébastien Dharancy; Philippe Mathurin; Pauline Jouet; Marie-Astrid Piquet; Thierry Davion; Frédéric Oberti; Philippe Broët; Dominique Emilie
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

10.  The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.

Authors:  E H Forrest; A J Morris; S Stewart; M Phillips; Y H Oo; N C Fisher; G Haydon; J O'Grady; C P Day
Journal:  Gut       Date:  2007-07-12       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.